Cognex Corporation (CGNX)
Technology
Scientific & Technical Instruments
65.20 $
Closing price · As of: 31. Jul 2026
Who owns Cognex Corporation (CGNX)? This page shows the largest institutions and funds, the ownership structure and the latest insider transactions. 95.4% of the shares are freely tradable; institutional investors hold 104.2%.
Ownership Structure
Institutional ownership
Share of the stock held by institutional investors (funds, banks, insurers) according to regulatory filings.
104.2%
Float
Share of stock freely tradable on the market — not locked up in the hands of founders, insiders, or major shareholders.
95.4%
Short % of float
Shares sold short as a percentage of the freely tradable float — high values signal many bets on falling prices.
4.5%
Shares Outstanding
Total number of shares issued. Price times share count gives market cap.
166Mio.
Largest Shareholders
Institutions
| Name | Stake (%) | Shares | Change (%) | Date |
|---|---|---|---|---|
| Vanguard Group Inc | 11.16 | 18,576,640 | -0.1 | 12/31/2025 |
| BlackRock Inc | 9.76 | 16,242,095 | -0.2 | 03/31/2026 |
| Vanguard Portfolio Management, LLC | 6.23 | 10,370,647 | +0.0 | 03/31/2026 |
| Vanguard Capital Management, LLC | 4.46 | 7,430,156 | +0.0 | 03/31/2026 |
| Pictet Asset Manangement SA | 4.01 | 6,673,031 | -4.9 | 03/31/2026 |
| Nordea Investment Mgmt Bank Demark A/s | 3.69 | 6,141,618 | -24.2 | 03/31/2026 |
| State Street Corp | 3.16 | 5,261,500 | +0.9 | 03/31/2026 |
Funds
| Name | Stake (%) | Shares | Change (%) | Date |
|---|---|---|---|---|
| Pictet - Robotics I dy EUR | 3.56 | 5,930,805 | -6.0 | 02/28/2026 |
| iShares Core S&P Mid-Cap ETF | 3.38 | 5,621,581 | +0.0 | 05/29/2026 |
| Vanguard Total Stock Mkt Idx Inv | 3.17 | 5,278,130 | +0.2 | 04/30/2026 |
Largest reported positions according to regulatory filings; stake as a percentage of shares outstanding, change versus the previous filing. Source: fundamentals data.
Data as of: July 31, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.